Avaliação de dor torácica na unidade de emergência ­ é possível associar os escores de risco cardiovascualr (TIMI, HEART E GRACE) e a presença de placa obstrutiva na angiotomografia de coronárias? / Assessment of chest pain in the emergency unit ­ is it possible to associate cardiovascular risk scores (TIMI, HEART AND GRACE) and the presence of obstructive plaque on coronary computed tomography angiography?

INTRODUÇÃO: Estima-se que quatro milhões de pacientes sejam atendidos anualmente em serviços de emergência do Brasil com a queixa de dor torácica, dos quais apenas 10% serão diagnosticados com síndrome coronariana aguda. Nesse contexto, escores de risco cardiovascular, como TIMI, HEART e GRACE, são utilizados como ferramenta para avaliar a possibilidade de doença arterial coronária (DAC). Inicialmente validados para estimar risco de eventos cardíacos intra-hospitalares, a sua associação com a presença de placa obstrutiva é pouco conhecida. OBJETIVO: Correlacionar os achados na Angiotomografia de Coronárias (Angio-TC) e os escores de risco cardiovascular, nos pacientes atendidos com dor torácica no pronto-socorro de hospital terciário. METODOLOGIA: Estudo observacional retrospectivo, baseado na análise de prontuários, no período de janeiro de 2019 a dezembro de 2021. Foram incluídos pacientes atendidos em pronto-atendimento de hospital terciário com a queixa principal de dor torácica aguda com valores de troponina negativos e ECG sem achados isquêmicos, submetidos a Angio-TC. Lesões coronárias ateroscleróticas foram quantificadas quanto à proporção de estenose luminal, sendo consideradas significativas aquelas com estenose ≥ 50% da luz do vaso em ≥ 1 artéria epicárdica relevante. RESULTADOS: Foram avaliados 350 pacientes com idade média de 52,6±11,9 anos, sendo 50% mulheres (Tabela 1). Desses pacientes, 72 (20,6%) apresentaram lesão aterosclerótica significativa em Angio-TC. Sexo masculino (OR: 1,87; IC 95%: 1,08 ­ 3,26), idade > 52 anos (OR: 2,85; CI 95%: 1,6 ­ 5,07), diagnóstico de Diabetes Mellitus (OR 2,17; IC 95%: 1,12 ­ 4,2) e relato de angina típica (OR 2,17; IC 95%: 1,12 ­ 4,2) estiveram associados de forma independente à presença de placa obstrutiva. Mais de 90% dos pacientes com lesão significativa na Angio-TC, apresentavam escore GRACE e TIMI de baixo risco. O escore HEART < 4 foi calculado em 23,6% dos pacientes com placa obstrutiva (Figura 1). CONCLUSÕES: A avaliação baseada em características clínicas e nos escores de risco cardiovascular de forma isolada não se mostrou suficiente para excluir de forma segura o diagnóstico de doença arterial coronária. Dessa forma, a Angio-TC é ferramenta complementar importante para o diagnóstico de coronariopatia nos pacientes com dor torácica aguda, possibilitando o início precoce de terapêutica adequada para a prevenção de novos eventos cardiovasculares.

Cardiomiopatia hipertrófica apical x infarto apical: strain longitudinal ou ressonância magnética? / Apical hypertrophic cardiomyopathy vs. apical infarction: longitudinal strain or MRI?

INTRODUÇÃO: A cardiomiopatia hipertrófica apical (CMHA) ou síndrome de Yamaguchi é uma condição relativamente rara, que apresenta acometimento predominante da região apical do ventrículo esquerdo (VE). O Ecocardiograma com strain nesta condição apresenta uma redução no ápice bem semelhante à imagem obtida no Infarto Apical. Descrevemos um caso onde as duas condições estavam presentes. (Figuras 1 -4) RELATO DE CASO: Masculino, de 78 anos, previamente hipertenso, procurou o pronto socorro por dor precordial teve o diagnóstico de infarto sem supra do segmento ST. Seu eletrocardiograma evidenciava ondas T profundas na parede anterior e lateral. Submetido à estratificação invasiva, sendo evidenciada coronária direita (CD) ocluída no terço proximal (CD), com circulação colateral presente e lesão grave em terço proximal de artéria circunflexa (Cx). Foi submetido à angioplastia com stent farmacológico na CX. Um mês após o evento coronariano agudo, o paciente retorna ao serviço referindo persistência de dor precordial, semelhante ao quadro anterior. Mantinha-se em uso de dupla antiagregação plaquetária, de modo que foi optado por nova estratificação invasiva, que revelou as mesmas lesões previamente citadas, com stent farmacológico em Cx apresentando fluxo TIMI 3. Ao ECO com strain, evidenciou-se aumento isolado da espessura da região apical do VE, medindo 15mm, com contratilidade miocárdica preservada nesta região, redução do strain global de 11.2% e área de redução muito acentuada sugerindo fibrose nessa mesma região poupando as demais paredes. Neste momento, não foi possível a determinação da causa da redução do strain apical, se IAM, Takotsubo ou CMH. A ressonância magnética cardíaca (RMC) com estresse com dipiridamol observou hipertrofia miocárdica assimétrica apical com carga fibrótica de 16% e presença de isquemia miocárdica em segmentos inferosseptal e inferior medioapical, além de realce tardio de padrão não coronariano acometendo a porção apical do VE, com fração de ejeção de 66%. CONCLUSÃO: A identificação da etiologia da fibrose apical só foi possível com a ressonância magnética, que deixou claro ser decorrente da CMHA, já que o padrão de realce era não coronariano. Ao estresse com Dipiridamol, evidenciou isquemia na parede inferior e inferosseptal medioapical determinando que a dor precordial tinha como causa a circulação colateral insuficiente da CD. Concluímos pela necessidade do diagnóstico ser multimodalidades de imagem, com resultados mais conclusivos com RMC.

Blood pressure control in a registry of clinical practice, PINNACLEBRAZIL REGISTRY

INTRODUCTION: The prevalence of hypertension is estimated to be nearly 50% among Brazilian adults. Achieving an adequate control of this CVD risk factor is challenging but truly relevant on a public health perspective, as this is the top ranking cause of all deaths globally. PURPOSE: We aimed to describe crude and simple metrics of blood pressure management (including its control), as based on current guidelinederived recommendations, after one year of the clinical practice registry METHODS: Patients with documented Hypertension were included by using electronic case report form based on the ACC PINNACLE Registry. The registry has been enrolling patients from general practitioners and specialists. The main goal of the PINNACLE program is to improve the quality of care in "real world" clinical practice. Patients data were evaluated after 01 year of follow-up on regular clinical appointments and the differences on clinical practice were evaluated RESULTS: Currently, PINNACLEBrazil has enrolled 7598 patients, with 87% of diagnosed hypertension. Percentage of patients with a diagnosis of hypertension who had a blood pressure measurement <140/90 mmHg was 47.9%(baseline) and 57.3% (followup). Percentage of patients who had a blood pressure < 140/90 mm Hg, or who had a blood pressure >= 140/90 mm Hg and were prescribed >= 2 antihypertensive medications were 67.1% on baseline and 71.2% after 1 year. CONCLUSION: The preliminary data of PINNACLE Registry in Brazil shows that a significant proportion of hypertensive patients (nearly half) have not presented with adequate control of blood pressure levels and, moreover, a large proportion have not been treated with recommended combination of 02 or more antihypertensive medications to reach targeted BP levels the quality of care was improving after 01 year of registry. (AU)

MINOCA por mixoma atrial esquerdo: relato de caso / Left atrial myxoma MINOCA: case report

INTRODUÇÃO: O termo MINOCA (Myocardial Infarction with Nonobstrutive Coronary Arteries) é utilizado para se referir aos casos de infarto agudo do miocárdio (IAM) em que na angiografia as artérias coronárias são normais. A MINOCA representa 14% de todas as causas de IAM, sendo mais frequente em mulheres jovens. Os mixomas são os tumores benignos primários do coração mais frequentes (40-50%). RELATO DE CASO: VMF, 49 anos, sexo feminino, apresentando dispneia aos esforços há 4 meses. O eletrocardiograma evidenciou área eletricamente inativa anterior extensa (figura 1) e o ecocardiograma (figura 2), fração de ejeção de ventrículo esquerdo (VE) de 55% (método Simpson), acinesia do ápice e dos segmentos apicais de todas as paredes e presença de imagem sugestiva de massa homogênea, com contornos regulares, localizada no interior do átrio esquerdo, medindo 25x28mm. Foi submetida à ressecção tumoral, com anatomopatológico confirmando mixoma atrial esquerdo. Paciente manteve seguimento ambulatorial, onde realizou angiotomografia de coronárias com escore de cálcio de zero, sem placas ateroscleróticas ou redução luminal. A ressonância magnética cardíaca (RMC), figura 3, mostrou fibrose miocárdica difusa, transmural, poupando apenas os segmentos anterolateral e inferolateral basais, com áreas de fibrose microvascular. A paciente evoluiu com disfunção ventricular, recebendo o tratamento medicamentoso recomendado. DISCUSSÃO: O diagnóstico de MINOCA na evolução deste caso pode ser bem estabelecido pelas alterações eletrocardiográficas, ecocardiográficas e, principalmente pelas alterações da RMC com a comprovação de realce tardio transmural de padrão coronariano. Foram afastadas lesões coronárias estruturais pela angiotomografia coronária. A presença de massa tumoral atrial esquerda levanta a possibilidade de embolização coronária, seja por fragmentos da massa ou por trombos formados pela sua presença, ou ainda por estado de hipercoagulabilidade induzida pelo tumor. A presença de embolização sistêmica em portadores de mixoma de átrio esquerdo é bem conhecida, embora o diagnóstico de embolia coronária seja extremamente rara. CONCLUSÃO: Massas tumorais cardíacas devem ser lembradas diante de casos de MINOCA, e um ecocardiograma e RMC são métodos diagnósticos importantes para confirmação deste diagnóstico. O tratamento cirúrgico precoce e possivelmente anticoagulação devem ser considerados para prevenção desta ocorrência

Epicardial fat accumulation, cardiometabolic profile and cardiovascular events in patients with stages 3-5 chronic kidney disease.

BACKGROUND: It has been hypothesized that epicardial adipose tissue (EAT) exerts pathogenic effects on cardiac structures. We analysed the associations between EAT and both cardiovascular (CV) disease risk factors and CV events in patients with chronic kidney disease (CKD). PATIENTS AND METHODS: We included 277 nondialysed patients [median age 61, interquartile range (IQR) 53-68 years; 63% men] with stages 3-5 CKD in this cross-sectional evaluation. EAT and abdominal visceral adipose tissue (VAT) were assessed by computed tomography. Patients were followed for median 32 (IQR 20-39) months, and the composite of fatal and nonfatal CV events was recorded. RESULTS: With increasing EAT quartiles, patients were older, had higher glomerular filtration rate, body mass index, waist, VAT and coronary calcification, higher levels of haemoglobin, triglycerides, albumin, C-reactive protein and leptin and higher prevalence of left ventricular hypertrophy and myocardial ischaemia; total and high-density lipoprotein cholesterol, 25-hydroxy-vitamin D and 1, 25-dihydroxy-vitamin D progressively decreased. Associations between EAT and cardiac alterations were not independent of VAT. During follow-up, 58 CV events occurred. A 1-SD higher EAT volume was associated with an increased risk of CV events in crude [hazard ratio (HR) 1.41, 95% confidence interval (CI) (1.12-1.78) and adjusted (HR 1.55, 95% CI 1.21-1.99) Cox models. However, adding EAT to a standard CV disease risk prediction model did not result in a clinically relevant improvement in prediction. CONCLUSION: Epicardial adipose tissue accumulation in patients with CKD increases the risk of CV events independent of general adiposity. This is consistent with the notion of a local pathogenic effect of EAT on the heart or heart vessels, or both. However, EAT adds negligible explanatory power to standard CV disease risk factors.

Epicardial fat accumulation, cardiometabolic profile andcardiovascular events in patients with stages 3–5 chronickidney disease

Cordeiro AC, Amparo FC, Oliveira MAC,Amodeo C, Smanio P, Pinto IMF, Lindholm B,Stenvinkel P, Carrero JJ (Karolinska Institutet,Stockholm, Sweden; Dante Pazzanese Institute ofCardiology, S~ao Paulo; Dante Pazzanese Institute ofCardiology, S~ao Paulo; Dante Pazzanese Instituteof Cardiology, S~ao Paulo; Dante Pazzanese Instituteof Cardiology, S~ao Paulo, Brazil). Epicardialfat accumulation, cardiometabolic profile andcardiovascular events in patients with stages3–5 chronic kidney disease.

Uterus transplantation model in sheep with heterotopic whole graft and aorta and cava anastomoses.

Uterine transplantation in the sheep model has been described as a partial or whole orthotopic graft from a living donor with vascular anastomoses. As an alternative to surrogate pregnancy or adoption uterus transplantation might be indicated for cases of infertility of uterine origin. The main complications might be rejection and thrombosis. The objective of this work was to develop a model of whole uterus transplantation that was applicable to the human setting, using grafts obtained from brain-dead donors, and suitable for immunologic and viability follow-up with a reduced risk of thrombosis. Two donors and 1 recipient were operated. The first graft was used for an anatomic study; the second was used for transplantation. The donor operation consisted of an en bloc harvest of the uterus, adnexa, and proximal vagina with the distal aorta and cava. After harvest the donor sheep was humanely killed. In the recipient ewe, heterotopic implantation was performed in the lower abdomen. An End-to-side anastomoses of aorta and cava were performed below the recipient's renal vessels. A cutaneous vaginal stoma was performed in the right lower quadrant. The recipient ewe was humanely killed for an autopsy study. The anatomy of uterine veins of the ewe differs from the human. The uterine and ovarian veins join, forming the utero-ovarian vein, which drains at the confluence of the common iliac to the cava. En bloc harvesting allows for rapid graft preparation, with vascular cuffs easily anastomosed with a low risk of thrombosis. The vaginal stoma seems appropriate to facilitate follow-up and graft biopsy. This approach can be a suitable experimental model applicable to humans using grafts from brain-dead donors.

Association between panel reactive antibodies and acute small bowel rejection: analysis of a series of 324 intestinal transplants.

INTRODUCTION: Panel reactive antibodies (PRA) to class I and II HLA molecules have been associated with acute kidney graft rejection, but their role in small bowel transplantation has not been characterized. METHODS: Since 1994, 324 SBT, alone or as multivisceral transplantation (MVT), have been performed in 286 patients. Routine and surveillance biopsies were performed to rule out or confirm acute rejection (AR), and PRA quantification was performed at varying intervals. We obtained data from 110 patients and 651 PRA measurements. While AR grade (mild to severe, grades 1-3) was determined by histopathological analysis, the status of no AR was determined also by clinical data. When biopsy samples or PRA measurements were frequent around an AR episode within periods of 7 days, the highest value was used. RESULTS: A comparison could be made between 259 instances in which there was a PRA measurement and simultaneous rejection evaluation. Positive PRA showed association with AR (P < 0.001). The positive and negative predictive values were 44% and 79%, respectively. No correlation was found in the severity of rejection. CONCLUSION: The presence of increased levels of PRA is a risk factor of rejection in small bowel transplantation. Alloantibody-mediated injury to the graft contributes frequently to acute rejection of small bowel, and it is associated with cell-mediated immunity in variable proportion.

Exclusions and deaths on the liver transplant waiting list.

OBJECTIVE: To analyze the characteristiscs, evolution and survival of patients included on the waiting list (WL) for liver transplantation (OLT). PATIENTS AND METHODS: Between February 2002 and April 2009, 254 patients were included on WL to receive a first graft. Two hundred twenty-two patients (87.4%) were transplanted (group T); 7 (2.8%) died on the WL and 25 (9.8%) were excluded, namely, 13 (52%) due to improvement (group IE) and 12, for other reasons (group OE). Data collected prospectively were analyzed retrospectively. RESULTS: Indications for transplant were cirrhosis (58%), hepatocellular carcinoma (HCC; 29%) and other etiologies (13%.) Average time on the WL was 60.3 +/- 62.9 days. Significant differences were not observed among the groups with respect to age, gender, or indication for OLT. The probability for exclusion due to progression and/or death was not significantly greater among patients included for HCC than for other reasons (P = .6). Survivals at 1, 3, and 5 years after WL inclusion were 81.2%, 73.3%, and 68.6%, respectively, in the whole series; and 85,4%, 76,9%, and 71.7% in group T. All group OE patients died before the first year, while group IE showed a survival of 100%, 91.7% and 91.7% at 1, 3, and 5 years, respectively. Survival was not different between groups T and IE (P = .03), but was lower in group OE than in groups T or IE (P < .001). CONCLUSION: The list mortality rate in our series was low, probably in relation to the short waiting time. The rate of exclusion from WL was 10%. Patient with hepatocellular carcinoma were not at an increased risk of WL exclusion. Patients excluded due to improvement displayed excellent survivals during the 5 years following exclusion.

Portoumbilical anastomosis as a simple method of transient portosystemic shunt during liver transplantation.

BACKGROUND: This article describes a new method of transient intraoperative portosystemic shunting, Splachnic edema after portal cross-clamping can be a dangerous complication during the anhepatic phase of the liver transplant operation. The current method seeks to avoid this problem, without the use of external venovenous bypass pump, by a temporary portocaval shunt, with retrohepatic cava preservation as first described experimentally in dogs by Fonkalsrud et al in 1966. METHODS AND RESULTS: Among 227 liver transplant operations, we utilized a transient portosystemic shunt in 29 cases. The indication to perform a temporary shunt in all cases was the development of splachnic edema. In 3 instances, we performed a portoumbilical anastomosis using a prominent umbilical vein. The other 26 procedures employed the usual portocaval shunts. In these cases, splachnic congestion and onset of edema developed after cross-clamping of the round ligament and the portal vein, which resolved after the portoumbilical anastomosis. DISCUSSION: The flow in the shunt was in all cases greater than 1 L/min. The most important risk factor for the development of splachnic edema was the presence of a patent umbilical vein, which occurred in 34.5% of shunted patients. CONCLUSION: The use of a patent umbilical vein to perform a portoumbilical shunt was an effective, easy method to decompress the splachnic area, avoiding dangerous congestion and edema.

Renoportal anastomosis as a rescue technique in postoperative portal thrombosis in liver transplantation.

Renoportal anastomosis has been used as the primary portal revascularization technique in grade 4 portal thrombosis, but never after posttransplant portal thrombosis. A cirrhotic patient with hepatocellular carcinoma and partial portal thrombosis of two-thirds of the lumen was transplanted. The thrombus was removed and good portal flow obtained upon reperfusion (2.8 L/min). On the ninth postoperative day Doppler ultrasound revealed complete portal thrombosis extending from the splenomesenteric confluence. At emergency reoperation, we removed the newly formed thrombus. Portal vein branches were flushed with heparin and urokinase. After reconstruction of the anastomosis, we achieved a flow of 1.1 L/min. Rethrombosis occurred again on day 13. At reoperation, thrombus was removed again. However, this time portal flow was not recovered, due to hepatofugal flow associated with both the presence of collaterals and pancreatic edema. A left renoportal anastomosis was performed using an interposed iliac vein graft. A catheter was placed into the portal vein through a recanalization of the umbilical vein of the graft. After urokinase perfusion, portal inflow was 1.7 L/min. The postoperative course was satisfactory, with progressive normalization of liver tests and no further thrombosis. Persistent ascites improved with treatment. Angiography on day 41 showed good portal flow from the renal vein, with uniform distribution within the liver. A renoportal anastomosis can be useful for recovery of liver failure after posttransplant portal thrombosis, in the absence of portal flow.

Surface and hemocompatibility studies of bi-soft segment polyurethane membranes.

Cross-linked urethane/urea membranes with two soft segments were prepared by extending a poly(propylene oxide) based tri-isocyanate-terminated prepolymer (PUR) with polybutadiene diol (PBDO). The ratio of prepolymer and polybutadiene diol was varied to yield cross-linked membranes with different compositions, exhibiting different degrees of phase-separation of the PBDO segments in the bulk and of surface enrichment in PUR. In this work, surface energy and hemocompatibility aspects (hemolysis and thrombosis) of the PUR/PBDO membranes were evaluated. The results showed that the membrane surface energy increased with the PBDO content until 25% of PBDO, and decreased thereafter. The introduction of the second, more hydrophobic, soft segment (PBDO) in the PUR membranes turned hemolytic into non-hemolytic membranes and, for a blood-material contact time of 10 minutes, decreased the thrombogenicity significantly. The 10% PBDO membrane was the least thrombogenic and was also non-hemolytic. The hemolysis degree did not vary significantly with the PBDO content while, for blood-material contact times of 10 minutes, the thrombogenicity increased with an increase in PBDO content above 10%. Membrane thrombogenicity varied with the blood-material contact time. For blood contact times of 10 minutes, all membranes tested were less thrombogenic than glass.

Five-year follow-up of a trial comparing Tacrolimus and cyclosporine microemulsion in liver transplantation.

We evaluate 5-year results of a prospective randomized trial that compared cyclosporine microemulsion (CsA-me) and Tacrolimus (Tac) for primary immunosuppression. One hundred one adult patients undergoing liver transplantation were randomized to receive Tac (n = 50) or CsA-me (n = 51). The most frequent indication for the procedure was cirrhosis due to virus C followed by alcoholism. Survival rates at 1, 3, and 5 years were 86%, 75%, and 72%, respectively; there was no significant difference between CsA-me versus Tac arms. Acute rejection occurred in 30 cases (30%), independent of the type of primary immunosuppression. Serious adverse events were reported significantly more among patients under CsA-me (48 episodes) than under Tac (32 episodes). Nineteen patients were switched to the other calcineurin inhibitor. The switch was much more frequent from CsA-me to Tac (n = 15; 29.4%), mainly because of lack of efficacy (n = 10; 19.6%). There were no cases of chronic rejections in the Tac arm. Four patients were switched from Tac to CsA-me for side effects; only 1 remains alive, after treatment was changed from CsA-me to an antimetabolite. There were no statistical differences in renal dysfunction, diabetes, hypertension, neurologic disorders, new-onset malignancies, or infections. There were no differences in survival or rejection among the intention-to-treat groups. Serious adverse events, total patients with switch of calcineurin inhibitor, as well as switches due to lack of efficacy, were statistically more frequent under CsA-me. Tacrolimus seems to be a more appropriate drug to be used for primary immunosuppression in liver transplantation.

Biological relevance of E-cadherin-catenin complex proteins in primary epithelial ovarian tumours.

This study analysed the biological relevance of E-cadherin, alpha-catenin, beta-catenin and gamma-catenin immunoexpression pattern (reduced vs. preserved phenotype) in epithelial ovarian tumours. Immunohistochemistry was used to evaluate the expression of these proteins in 154 epithelial ovarian tumours, consisting of 17 benign, 33 borderline and 104 malignant tumours. In borderline tumours, the immunoexpression pattern of E-cadherin (p = 0.014) and alpha-catenin (p = 0.030) associated with histological type. In malignant tumours, the immunoexpression pattern of E-cadherin was related with histological type (p = 0.001). The immunoexpression pattern of beta-catenin associated with histological type and tumour differentiation (p = 0.005, p = 0.025, respectively). The preserved phenotype of E-cadherin was most frequently observed in mucinous tumours, whereas reduced E-cadherin was most frequently observed in serous tumours. The preserved phenotype of beta-catenin associated with endometrioid carcinomas, while reduced beta-catenin associated with poorly differentiated serous and clear cell carcinomas. Although the reduced phenotype was the most frequent immunoexpression observed for all proteins of the E-cadherin-catenin complex in epithelial ovarian tumours, only beta-catenin showed a significant difference between benign, borderline and malignant tumours (p = 0.045), since borderline and malignant tumours most frequently showed the reduced phenotype. The immunohistochemical profile of beta-catenin was shown to be of biological relevance: reduced beta-catenin was correlated with loss of tumour differentiation and serous carcinomas that are known to depict aggressive biological behaviour in epithelial ovarian tumours.

Rejection properties of stochastic-resonance-based detectors of weak harmonic signals.

In [Phys. Rev. E 57, 6470 (1998)]] a thorough characterization in terms of receiver operating characteristics of stochastic-resonance detectors of weak harmonic signals of known frequency in additive Gaussian noise was given. It was shown that strobed sign-counting based strategies can be used to achieve a nice trade-off between performance and cost, by comparison with noncoherent correlators. Here we discuss the more realistic case where besides the sought signal (whose frequency is assumed known) further unwanted spectrally nearby signals with comparable amplitude are present. Rejection properties are discussed in terms of suitably defined false-alarm and false-dismissal probabilities for various values of interfering signal(s) strength and spectral separation.

Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study.

BACKGROUND: Restenosis remains an important limitation of interventional cardiology. Therefore, we aimed to determine the safety and efficacy of sirolimus (a cell-cycle inhibitor)-coated BX Velocity stents. METHODS AND RESULTS: Thirty patients with angina pectoris were electively treated with 2 different formulations of sirolimus-coated stents (slow release [SR], n=15, and fast release [FR], n=15). All stents were successfully delivered, and patients were discharged without clinical complications. Independent core laboratories analyzed angiographic and 3D volumetric intravascular ultrasound data (immediately after procedure and at 4-month follow-up). Eight-month clinical follow-up was obtained for all patients. There was minimal neointimal hyperplasia in both groups (11.0+/-3.0% in the SR group and 10.4+/-3.0% in the FR group, P:=NS) by ultrasound and quantitative coronary angiography (in-stent late loss, 0.09+/-0.3 mm [SR] and -0.02+/-0.3 mm [FR]; in-lesion late loss, 0.16+/-0.3 mm [SR] and -0.1+/-0.3 mm [FR]). No in-stent or edge restenosis (diameter stenosis >or=50%) was observed. No major clinical events (stent thrombosis, repeat revascularization, myocardial infarction, or death) had occurred by 8 months. CONCLUSIONS: The implantation of sirolimus-coated BX Velocity stents is feasible and safe and elicits minimal neointimal proliferation. Additional placebo-controlled trials are required to confirm these promising results.

Percutaneous handling of coronary lesions >20mm through stents. Is there a first choice strategy?

OBJECTIVE - This study compared the early and late results of the use of one single stent with those of the use of multiple stents in patients with lesions longer than 20mm. METHODS - Prospective assessment of patients electively treated with stents, with optimal stent deployment and followed-up for more than 3 months. From February '94 to January '98, 215 patients with lesions >20mm were treated. These patients were divided into 2 groups as follows: Group A - 105 patients (49%) with one stent implanted; Group B - 110 patients (51%) with multiple stents implanted. RESULTS - The mean length of the lesions was 26mm in group A (21-48mm) versus 29mm in group B (21-52mm) (p=0.01). Major complications occurred in one patient (0.9%) in group A (subacute thrombosis, myocardial infarctionand death) and in 2 patients (1.8%) in group B (one emergency surgery and one myocardial infarction) (p=NS). The results of the late follow-up period (>6 months) were similar for both groups (group A = 82% vs group B = 76%; p=NS), and we observed an event-free survical in 89% of the patients in group A and in 91% of the patients in group B (p=NS). Angina (group A = 11% vs group B = 7%) and lesion revascularization (group A = 5% vs group B = 6%; p=NS) also occurred in a similar percentage. No infarction or death was observed in the late follow-up period; restenosis was identified in 33% and 29% of the patients in groups A and B, respectively (p=NS). CONCLUSION - The results obtained using one stent and using multiple stents were similar; the greater cost-effectiveness of one stent implantation, however, seems to make this strategy the first choice.

[Influence of the clinical presentation on immediate and long-term results after rotational atherectomy]. / Influência do quadro clínico nos resultados imediatos e tardios após aterectomia rotacional.

PURPOSE: To analyse the influence of unstable coronary syndromes (UCS) in the early and late prognosis after rotational atherectomy (RA). METHODS: We treated 236 patients with RA between Aug/1992 and May/1996. Patients were divided into two groups: A) stable coronary syndromes 120 (51%) patients; B) UCS: 116 (49%) patients. DEFINITIONS: 1) procedure success (PS)--lesion success in all locations were RA use was attempted, without a major complication; 2) late coronary events (LCE)--angina, MI, additional revascularization or death. RESULTS: There was a significant predominance of age > 70 (A = 14% x B = 24%, p = 0.03) in B and previous MI (A = 32% x B = 11%, p = 0.0001) in A. Other characteristics were similar in both groups, including complex lesions (type B2/C), which were observed in 77% A stenosis and 80% B lesions. PS was 95% in A and 92% in B (p = NS). In-hospital major complications were observed in 2.5% A and 4.3% B patients, (p = NS). One patient died in each group. A and B patients had similar time of follow-up. LCE occurred in 25% A and 39% B patients (p = 0.002). Recurrence of angina (36% x 23%; p = 0.01) and target lesion revascularization (29% x 18%; p = 0.03) were also more frequently required in B cases. CONCLUSION: This study suggests that UCS (group A) does not implicate in worse acute results after RA. However, UCS patients present greater incidence of late coronary events, particularly recurrence of angina and target-lesion revascularization.